#	Pagina
attuale pagina	/open-h2020/projects/196500/index.html
-1	/open-h2020/per-topic/philips/list/index.html
-2	/open-h2020/per-topic/braces/list/index.html
-3	/open-h2020/projects/205567/index.html
-4	/open-h2020/per-topic/microglial/list/index.html
-5	/open-h2020/projects/226148/index.html
-6	/open-h2020/per-topic/fhe/list/index.html
-7	/open-h2020/per-topic/pad/list/index.html
-8	/open-h2020/per-topic/forelimb/list/index.html
-9	/open-h2020/projects/196077/index.html
-10	/open-h2020/projects/195536/index.html

Opendata, web and dolomites

PREKIND

PreEclampsia diagnosis by Early Kidney Injury Detection

Total Cost €

EC-Contrib. €

Partnership

Views

Outcomes and
results

PREKIND project word cloud

Explore the words cloud of the PREKIND project. It provides you a very rough idea of what is the project "PREKIND" about.

sensitivity millions conduct claims plan predict spend annual diagnosis biomarker elisa vesna 75 prognostic worldwide 500 introduction surviving solutions garovic demonstrated ruo flow pe pregnant renal too specificity variety innovation 31billion symptoms cytometry ambition lives alone form health months babies feasibility licensed urine contribution accounts preelampsia 7billion mothers emerge3 care damage risk disease mayo preeclampsia rest life clinical sub exceptional foundation annually survive diagnostic year1 podocin diagnose informbio dr budgets antenatal org innovative pioneering deaths develops infant leader provision syndrome cardiovascular assays indicate usa ongoing ib http world pregnancy complications clinic 000 business women biomarkers estimates direct podocyte dealing tests

Project "PREKIND" data sheet

The following table provides information about the project.

Coordinator	INFORM BIOSCIENCE LIMITED Organization address address: HOFFMAN PARK LITTLE ISLAND COUNTY CORK city: CORK postcode: n.a. website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Ireland [IE]
Project website	http://www.informbio.com
Total cost	71˙429 €
EC max contribution	50˙000 € (70%)
Programme	1. H2020-EU.3.1.3. (Treating and managing disease)
Code Call	H2020-SMEINST-1-2014
Funding Scheme	SME-1
Starting year	2015
Duration (year-month-day)	from 2015-05-01 to 2015-07-31

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	INFORM BIOSCIENCE LIMITED INFORM BIOSCIENCE LIMITED Organization address address: HOFFMAN PARK LITTLE ISLAND COUNTY CORK city: CORK postcode: n.a. website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	IE (CORK)	coordinator	50˙000.00

Map

Project objective

Health Challenge: PreEclampsia (PE) claims the lives of 75,000 women annually and the 6,000,000 surviving mothers will have an increased risk of cardiovascular disease for the rest of their life. PE accounts for over 500,000 infant deaths worldwide every year1; and for the millions of babies that survive, they too will go on to have increased risk of a variety of health issues. PE is a syndrome that develops during pregnancy but presents no clinical symptoms during most of the pregnancy and is therefore currently complex to diagnose. Business Challenge: With an annual spend of over 31Billion in direct costs in the developed world alone, the provision of antenatal care to pregnant women has a significant impact on health care budgets; dealing with the immediate consequences of PE form an important contribution to this cost. The Preelampsia foundation (http://www.preeclampsia.org/) estimates the annual cost of PE is more than $7billion in the US. InformBio Business Innovation: InformBio (IB) has licensed pioneering research by Dr.Vesna Garovic of the Mayo Clinic, USA. The technology has identified podocyte specific biomarkers in urine that indicate ongoing renal damage and which allow for a sub-clinical diagnosis for PE. The key biomarker, podocin, has demonstrated exceptional sensitivity and specificity and can diagnose the disease up to 3 months before clinical symptoms emerge3. InformBio are currently working to develop flow cytometry and research use only (RUO) ELISA assays for the biomarker. InformBio’s ambition is to be the world leader in early pregnancy prognostic tests, offering the most innovative, cost effective solutions to predict pregnancy complications.

Phase 1 proposal: To conduct a feasibility study to support the development of a detailed business plan for the introduction of a PE diagnostic test.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PREKIND" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PREKIND" are provided by the European Opendata Portal: CORDIS opendata.